EEG Biomarkers for Predicting Response to Antidepressant Therapy - Related Studies

EEG Biomarkers for Predicting Response to Antidepressant Therapy

This study is ongoing, but not recruiting participants.

Study NCT00289523. Last updated on March 30, 2007. Information provided by Aspect Medical Systems

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Major Depressive Disorder

2	Additional conditions recognized in this trial
		Depression
		Depressive Disorder
		Depressive Disorder, Major

3	More general conditions related to this trial
		Behavioral Symptoms
		Mental Disorders
		Mood Disorders

4	Interventions listed in this trial
		Escitalopram, Bupropion XL

5	Additional drug interventions recognized in this trial
		Bupropion
		Citalopram
		Dexetimide

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Antiparkinson Agents
		Autonomic Agents
		Central Nervous System Agents
		Cholinergic Agents
		Cholinergic Antagonists
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Antagonists
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Parasympatholytics
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		Aspect Medical Systems